ライフサイエンスコーパス: new device

1 derived from the blood samples taken by the new device.

2 ous types of waveforms are possible with the new device.

3 We aimed to test this new device.

4 ived Gianturco-Roubin stents as an unplanned new device.

5 medium term, the safety and efficacy of the new device.

6 proof of concept of the capabilities of the new device.

7 applications in spintronics, and may lead to new devices.

8 significant potential for the development of new devices.

9 ilable with regard to the longevity of these new devices.

10 oducts while expediting access to beneficial new devices.

11 and extends its feasibility for varieties of new devices.

12 ational registries, and evolution of several new devices.

13 ker generators is not inferior to the use of new devices.

14 hem (57.7%) were ultimately reimplanted with new devices.

15 tional patient populations and the design of new devices.

16 nd metal cations are highly sought after for new devices.

17 and anterior chamber depth measurements of 2 new devices, 1 using Scheimpflug technology combined wit

18 ransformations performed side by side in the new device and a standard microwave reactor suggest that

19 luded if they described the development of a new device and a surgical application was described.

20 We created the new device and assessed it with in-vitro laboratory test

21 chip RNA extraction from infected cells, the new device and protocol can detect Ebola virus in raw bl

22 ctures is of utmost importance in developing new devices and applications of these materials.

23 the comparative effectiveness evaluation of new devices and approaches to treat MR.

24 y has since changed with the availability of new devices and drugs.

25 New devices and improvements in existing devices have re

26 Introduction of new devices and new techniques are increasing, as eviden

27 3x3 cm2) have all led to the development of new devices and optical probes to monitor physiological

28 e particular advantages in the evaluation of new devices and transcatheter interventions in chronic h

29 te variables (other than charge or voltage), new devices, and new architectures that offer memory and

30 normal) and late mortality after balloon and new device angioplasty has been reported previously.

31 al physical properties - and in turn promise new device applications - as a result of the coupling be

32 Our results point to new device applications such as magnetically recorded fe

33 usual electromagnetic properties and promise new device applications.

34 A new device architecture for fast organic transistor memo

35 vironments exhibits an important step toward new device architectures with potential relevance to bio

36 lucidating the device mechanisms, developing new device architectures, and improving large-scale manu

37 This imprinting strategy provides access to new device architectures, as demonstrated through the fa

38 New devices are becoming available which make the monito

39 New devices are currently engineered to prevent stone mi

40 from the amorphous character of a-ZITO, the new devices are highly flexible and can be repeatedly be

41 These new devices are introducing Raman spectroscopy to a dive

42 It is not clear whether new devices are more effective in this anatomic setting.

43 anic ions level could be evidenced with this new device, assisting the early diagnosis and prevention

44 view was to highlight new techniques and the new devices available to the pediatric interventional ca

45 We describe a new device based on gold-microtube membranes that can ac

46 The development of a new device based on the use of UV-vis bare optical fiber

47 Updates in the new Device-Based Therapy Guidelines for the implantation

48 There are new devices being examined in clinical trials, including

49 This new device can be ideal for preseparation and preconcent

50 We conclude that this new device can be used successfully for testing new agen

51 quality ferroelectric films now be grown for new device capabilities, but ferroelectrics can be combi

52 This new device concept is scalable and easily deployed for a

53 r across the interface as the foundation for new device concepts and applications.

54 solid-state organic lasers are reviewed, and new device concepts and emerging applications are summar

55 novel electronic and optical properties, and new device concepts not observed in bulk material system

56 ric films, and has led to the development of new device concepts such as resistive random-access memo

57 imensional materials has emerged in light of new device concepts taking advantage of flexing, adhesio

58 t has been devoted to find new materials and new device concepts that could ultimately outperform sta

59 ns in single-molecule circuits are heralding new device concepts with no classical analogues.

60 uit fabrication and create possibilities for new device concepts.

61 ot only lead to more stable devices but also new device concepts.

62 To combat this problem, we have developed a new device configuration, the double-gate light-emitting

63 The new device coupled with a portable electrochemical analy

64 We evaluated a new device designed to clean the endotracheal tube in me

65 vely slow and often limits the rate at which new device designs can be built and tested.

66 This new device enhances negative intrathoracic pressure duri

67 year, participants were randomly allocated a new device (EpiPen, Anapen, new EpiPen, JEXT or Auvi-Q),

68 d with a high procedural success rate in the new device era, they have an increased rate of major eve

69 atment of left main coronary stenoses in the new device era.

70 Recent advancement shows that a new device, 'flow-diverter', can divert blood flow away

71 We also introduced a new device for measuring in vivo fluorescence over time,

72 A new device for parallel-electromembrane extraction (Pa-E

73 We describe a new device for separation of complex biological particle

74 A new device for the assessment of dynamic torsion during

75 Here, we present a new device for the real-time monitoring of oxidative str

76 ential for application in the development of new devices for biosensing.

77 Despite the advent of many new devices for glaucoma surgery, scarring is the main c

78 ass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane o

79 as a theoretical framework for the design of new devices for more efficient water filtration and osmo

80 New devices for performing coronary interventions have b

81 growth of such lateral junctions will allow new device functionalities, such as in-plane transistors

82 semiconductors is a promising route towards new device functionality and performance.

83 Alternatives that are being pursued include new device geometries such as ultrathin channel structur

84 device available to clinicians, a number of new devices have become commercially available and have

85 Finally, three new devices have been developed to manipulate Leidenfros

86 New devices have recently been approved for use in adole

87 m the experimental data, indicating that the new devices hold promise for biomedical studies.

88 ith structurally normal hearts who underwent new device implantation at Texas Children's Hospital bet

89 ts receiving the Gianturco-Roubin stent as a new device in an unplanned fashion are included.

90 Gianturco-Roubin flex stents as an unplanned new device in the initial treatment of 350 patients (389

91 were no arm fractures with either the old or new devices in these dogs.

92 Highlights of these new devices include precisely adjustable absorption edge

93 magnetic rotations that might be applied in new devices including microwave sources and resonators.

94 embranes are expected to enable a variety of new devices, including membrane-based chromatography sys

95 The new device is highly flexible concerning the used separa

96 attractive performance and advantages of the new device is indicated from comparison to a conventiona

97 The new device is simple and is fast and accurate in measuri

98 which there are many), rather than creating new devices, is a desirable trend that may contribute to

99 Using the new device it was possible to characterize the potency o

100 This kind of new device may not only helpful to implement adaptive in

101 New devices may allow patients to complete visual field

102 Whether the use of new devices may attenuate the elevated risk of CABG in p

103 e innovations and technologies emerge, these new devices may become a cornerstone of the management s

104 Most new device models are deemed safe and effective without

105 rd cardiopulmonary resuscitation, use of the new device more than doubled short-term survival rates i

106 The new device, named "worm hospital" allows us to perform t

107 ess communications to become a reality, many new devices need to be developed, such as those for rout

108 New devices, new thrombolytic agents, and new antithromb

109 dictates the utility of FRET and can unlock new device operation motifs including quantum-funnel sol

110 perspectives on routes to commercialization, new device opportunities, and remaining challenges for r

111 ble metallic helical stent was explored as a new device opportunity (magnesium scaffold), which can b

112 of available airway devices, development of new devices, or both may help to promote this goal.

113 These new materials and new devices pave the way for a new generation of electro

114 t is used in the clinical laboratories, this new device performed well in regards to the analytical p

115 25 fmol of [Glu1]-fibrinopeptide B using the new device produced a CE-ESI-MS electropherogram with a

116 trial), and 1 placebo-controlled trial of a new device (Prosorba).

117 As technology continues to improve and new devices provide greater safety and durability, conti

118 tic waves and are an enabling technology for new devices ranging from flat lenses that focus light be

119 ozyme device platform to efficiently isolate new device sequences that exhibit increased in vitro cle

120 The availability of this new device should make this measurement technology acces

121 Whilst some of these new devices show promise in the outpatient setting, furt

122 Beyond this timeframe, entirely new device structures (such as nanowire or molecular dev

123 dielectrics and metal gate electrodes), and new device structures are required.

124 en the cornerstone of medical communication, new devices such as cellular telephones, personal digita

125 Studies of new devices such as laryngoscopes and the use of the lar

126 Such action will ensure timely access to the new device technologies that are necessary for the growt

127 New device technologies, such as intracoronary stenting;

128 New device technology developed in the clinical research

129 A new device technology is also presented that uses a meta

130 be accomplished safely and effectively with new device technology.

131 The new device, termed a periodic focusing ion funnel (PF IF

132 In this study, we present a new device that allows for high-resolution imaging of th

133 This study evaluates a new device that has been proposed to continuously monito

134 erative that close scrutiny be given to each new device that hits the market to ensure they perform o

135 stacking order in graphene opens the way to new devices that combine structural and electrical prope

136 rly review available devices and investigate new devices that emerge each year.

137 To overcome this constraint, we developed new devices that integrate ultrathin and flexible silico

138 This new device thus has the potential for rapid analysis of

139 The iStent inject is a promising new device to lower intraocular pressure via TM bypass.

140 A new device to perform spectroelectrochemical measurement

141 ent of acute ischemic stroke mainly focus on new devices to reperfuse ischemic brain.

142 for all condom failure events for the three new devices versus the FC2, within the predefined margin

143 With the development of new devices, vision screening can effectively be perform

144 During the index hospitalization, a new device was implanted in 54 patients at a median of 7

145 The analytical performance of these new devices was demonstrated using water samples spiked

146 The new device will enable high-throughput studies of quanta

147 ld confirmed the safety and efficacy of this new device, with vasomotion restoration and continued de

148 When switched to a new device without specific training, success rates were